Cervical Dysplasia During Adolescence And Their Management

Abstract

Aim: Adolescence is a period of life between 11 and 19 years old. Patients in this age group must be differentiated than older aged patients in accordance to spectrum of gynecologic disease and treatment modalities. HPV infection is common in sexually active adolescent girls. Most of the infections resolve spontaneously but sometimes persistent infection results cervical dysplasia formation. Cervical dysplasia might predispose to cancer formation but this occurs rarely in adolescence. In this text our aim was to take attention to adolescent HPV infection, cervical pathology screening and treatment options for cervical dysplasia.

Keywords

• Adolescence,HPV infections,cervical dysplasia

Adölesan Dönemde Servikal Displaziler Ve Yönetimi

Abstract

Amaç: Adölesan dönem 11-19 yaş arası gelişimsel geçiş dönemini tanımlamaktadır. Bu dönemin özelliği jinekolojik hastalıklar ve tedavi şekilleri açısından ileri yaş hasta gruplarından ayrı değerlendirilmesi gerektiğidir. Adölesan genç kızlarda özellikle cinsel aktivite başlangıcından sonra HPV enfeksiyonları oldukça sık görülmektedir. Bağışıklık sistemi çoğu HPV enfeksiyonunu spontan olarak yok etmektedir. Ancak bazı durumlarda HPV persistansı displazik servikal lezyonların oluşmasına sebep olmaktadır. Displazik lezyonlar zaman içerisinde invazif kansere dönüşebilir olsalar da bu oranlar adölesanlarda düşük olduğundan servikal kanser oldukça nadir görülür. Bu yazıda adölesanlarda HPV enfeksiyonunun seyri, servikal patoloji taramaları ve servikal displazilerin tedavisine değinilmiştir.

Keywords

• Adölesan,HPV enfeksiyonu,servikal displazi

References

1. Michala L, Argyri E, Tsimplaki E, et al. Human Papilloma Virus infection in sexually active adolescent girls. Gynecol Oncol. Aug 2012;126:207-210.
2. Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. Oct 2011;53.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. Sep 1999;189:12-19.
4. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. Jun 1 2001;183:1554-1564.
5. Monteiro DL, Sodre DC, Russomano FB, Trajano AJ, Silva KS. Incidence of genital warts in adolescents and their association with cervical intraepithelial lesions. Eur J Obstet Gynecol Reprod Biol. May 2013;168:80-82.
6. Schwarz TF, Huang LM, Medina DM, et al. Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10-14 years. J Adolesc Health. Feb 2012;50:187-194.
7. Roset Bahmanyar E, Paavonen J, Naud P, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. Dec 2012;127:440-450.
8. Monteiro DL, Trajano AJ, Russomano FB, Silva KS. Prognosis of intraepithelial cervical lesion during adolescence in up to two years of follow-up. J Pediatr Adolesc Gynecol. Aug 2010;23:230-236.

9. Syrjanen KJ. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). Eur J Obstet Gynecol Reprod Biol. Mar 1996;65:45-53.
10. McAllum B, Sykes PH, Sadler L, Macnab H, Simcock BJ, Mekhail AK. Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol. 2011;205:478.
11. Clements AE, Raker CA, Cooper AS, Boardman LA. Prevalence and patient characteristics associated with CIN 3 in adolescents. Am J Obstet Gynecol. 2011;204:128.
12. Freeman-Wang T, Walker P. Colposcopy in special circumstances: Pregnancy, immunocompromise, including HIV and transplants, adolescence and menopause. Best Pract Res Clin Obstet Gynaecol. Oct 2011;25:653-665.
13. Henderson JT, Saraiya M, Martinez G, Harper CC, Sawaya GF. Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med. Jan 2013;56:25-29.
14. Moscicki AB, Ma Y, Jonte J, et al. The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol Biomarkers Prev. 2010;19:2055-2065.